These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17377078)

  • 1. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa.
    Sniecinski RM; Chen EP; Levy JH; Szlam F; Tanaka KA
    Anesth Analg; 2007 Apr; 104(4):763-5. PubMed ID: 17377078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of and for the individual rather than the religious institution.
    Elder L
    Anesth Analg; 2007 Apr; 104(4):757-8. PubMed ID: 17377076
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal care for patients who are Jehovah's Witnesses.
    Schiller HJ
    Anesth Analg; 2007 Apr; 104(4):755-6. PubMed ID: 17377075
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant human coagulation factor VIIa in Jehovah's Witness patients undergoing liver transplantation.
    Jabbour N; Gagandeep S; Peilin AC; Boland B; Mateo R; Genyk Y; Selby R; Zeger G
    Am Surg; 2005 Feb; 71(2):175-9. PubMed ID: 16022020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding in a Jehovah's Witness patient undergoing a redo aortic valve replacement controlled with cryoprecipitate and a prothrombin complex concentrate.
    Robblee JA; Wilkes PR; Dickie SJ; Rubens FD; Bormanis J
    Can J Anaesth; 2012 Mar; 59(3):299-303. PubMed ID: 22161243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is blood and what is not? Caring for the Jehovah's Witness patient undergoing cardiac surgery.
    Sniecinski R; Levy JH
    Anesth Analg; 2007 Apr; 104(4):753-4. PubMed ID: 17377074
    [No Abstract]   [Full Text] [Related]  

  • 7. Prophylactic use of factor IX concentrate in a Jehovah's Witness patient.
    Bolliger D; Sreeram G; Duncan A; Molinaro RJ; Szlam F; Chen EP; Tanaka KA
    Ann Thorac Surg; 2009 Nov; 88(5):1666-8. PubMed ID: 19853132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature.
    Haan J; Scalea T
    Am Surg; 2005 May; 71(5):414-5. PubMed ID: 15986972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding.
    Kandane-Rathnayake RK; Isbister JP; Zatta AJ; Aoki NJ; Cameron P; Phillips LE;
    ANZ J Surg; 2013 Mar; 83(3):155-60. PubMed ID: 23035873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VII for a warfarinised Jehovah's Witness with an acute subdural haematoma.
    Goldberg R; Drummond KJ
    J Clin Neurosci; 2008 Oct; 15(10):1164-6. PubMed ID: 17702584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
    Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
    Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
    Majumdar G; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contemporary approach to the care of Jehovah's witnesses.
    Hughes DB; Ullery BW; Barie PS
    J Trauma; 2008 Jul; 65(1):237-47. PubMed ID: 18580506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.
    Virchis A; Hughes C; Berney S
    Hematol J; 2004; 5(3):281-2. PubMed ID: 15167918
    [No Abstract]   [Full Text] [Related]  

  • 15. How good patient blood management leads to excellent outcomes in Jehovah's witness patients undergoing cardiac surgery.
    Emmert MY; Salzberg SP; Theusinger OM; Felix C; Plass A; Hoerstrup SP; Falk V; Gruenenfelder J
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):183-8. PubMed ID: 20829389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from the outcome of bloodless emergency laparotomies on Jehovah's Witness women presenting in the extremis with ruptured uterus.
    Chigbu B; Onwere S; Kamanu C; Aluka C; Okoro O; Feyi-Waboso P; Onichakwe C
    Arch Gynecol Obstet; 2009 Apr; 279(4):469-72. PubMed ID: 18677500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anesthetic management of Jehovah's Witnesses patients undergoing open heart surgery with cardiopulmonary bypass].
    Kamata M; Oda T; Nomura T; Yamasaki A; Takahama Y; Yabuta N; Nakazawa H; Takahashi M
    Masui; 2011 Mar; 60(3):367-72. PubMed ID: 21485108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant activated factor VII in a Jehovah's Witness patient.
    Hsieh A; Cheong I
    Am J Emerg Med; 2007 Nov; 25(9):1085.e1-2. PubMed ID: 18022514
    [No Abstract]   [Full Text] [Related]  

  • 19. Care of the injured Jehovah's Witness patient: case report and review of the literature.
    Kulvatunyou N; Heard SO
    J Clin Anesth; 2004 Nov; 16(7):548-53. PubMed ID: 15590263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac surgery in Jehovah's Witnesses. Experience in Santander, Spain].
    Bernal JM; Naranjo S; Trugeda M; Sarralde A; Diago C; Revuelta JM
    Rev Esp Cardiol; 2006 May; 59(5):507-9. PubMed ID: 16750149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.